ArticleBMC veterinary research2019

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.

Ian J Passmore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.